KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Other financing activities (2016 - 2020)

Evolent Health (EVH) has 6 years of Other financing activities data on record, last reported at $33.7 million in Q1 2020.

  • For Q1 2020, Other financing activities rose 5439.14% year-over-year to $33.7 million; the TTM value through Mar 2020 reached -$70.0 million, down 426.29%, while the annual FY2019 figure was -$104.3 million, 208.44% down from the prior year.
  • Other financing activities reached $33.7 million in Q1 2020 per EVH's latest filing, up from -$104.9 million in the prior quarter.
  • Across five years, Other financing activities topped out at $33.7 million in Q1 2020 and bottomed at -$104.9 million in Q4 2019.
  • Average Other financing activities over 5 years is -$5.9 million, with a median of $607500.0 recorded in 2019.
  • Peak YoY movement for Other financing activities: surged 1240.5% in 2017, then surged 5439.14% in 2020.
  • A 5-year view of Other financing activities shows it stood at $1.6 million in 2016, then soared by 1240.5% to $21.4 million in 2017, then crashed by 102.83% to -$608000.0 in 2018, then crashed by 17149.18% to -$104.9 million in 2019, then skyrocketed by 132.11% to $33.7 million in 2020.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $33.7 million in Q1 2020, -$104.9 million in Q4 2019, and $607000.0 in Q3 2019.